Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/03/2012
PIL Roaccutane 10mg and 20mg Soft Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
Updated on 02/03/2012 and displayed until 13/03/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/02/2012 and displayed until 02/03/2012
Reasons for adding or updating:
  • Change to Further Information section
Updated on 29/07/2011 and displayed until 09/02/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 08/04/2011 and displayed until 29/07/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 11/11/2010 and displayed until 08/04/2011
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
Updated on 19/10/2010 and displayed until 11/11/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/10/2009 and displayed until 19/10/2010
Reasons for adding or updating:
  • Change of contra-indications
Updated on 14/10/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 28/09/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/09/2009 and displayed until 28/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/03/2009 and displayed until 25/09/2009
Reasons for adding or updating:
  • Addition of joint PIL covering all presentations
Updated on 22/02/2007 and displayed until 04/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/02/2007 and displayed until 22/02/2007
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 14/02/2006 and displayed until 09/02/2007
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 28/02/2005 and displayed until 14/02/2006
Reasons for adding or updating:
  • Change to packaging
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 12/02/2002 and displayed until 28/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 24/09/2001 and displayed until 12/02/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 14/08/2000 and displayed until 24/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  isotretinoin